I-Remdesivir Intermediate CAS 1770840-43-1 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine COVID-19
Umkhiqizi Wokuhlinzeka Ngempahla Yezohwebo i-Remdesivir kanye Nezixhumanisi Ezihlobene Nekhwalithi Ephezulu
I-Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
I-Trimethylsilyl Cyanide CAS 7677-24-9
I-4-Nitrophenol CAS 100-02-7
2-Ethylbutyl ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
I-Remdesivir Metabolite (GS-441524) CAS 1191237-69-0
I-Remdesivir N-2 I-CAS Emaphakathi 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5
I-Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Igama Lekhemikhali | 4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine |
Omqondofana | 7-Iodopyrrolo[2,1-f][1,2,4]triazin-4-amine;I-Remdesivir-004;I-Remdesivir Ukungcola 30 |
Inombolo ye-CAS | 1770840-43-1 |
Inombolo yeCAT | I-RF-PI304 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu |
I-Molecular Formula | I-C6H5IN4 |
Isisindo samangqamuzana | 260.04 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Ephuzi Ekhanyayo ukuya Ensundu |
I-Infrared Spectrum | Ivumelana Nesakhiwo |
Ubumsulwa | ≥98.0% (HPLC) |
Ukulahlekelwa Ekumisweni | ≤0.50% |
Ukungcola Okukodwa | ≤0.50% |
Izinsimbi Ezisindayo | ≤20ppm |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-Intermediate ye-Remdesivir (CAS 1809249-37-3) |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine (CAS 1770840-43-1) iyi-Intermediate of Remdesivir (CAS 1809249-37-3).I-Remdesivir iyinhlanganisela ye-antiviral esetshenziselwa ukuvimbela isenzo se-RNA polymerase.I-Remdesivir ekuqaleni yayiphenywa njengendlela yokwelapha igciwane le-Ebola, kodwa inamandla okwelapha amagciwane ahlukahlukene e-RNA.Umsebenzi wayo ngokumelene nomndeni we-coronavirus (CoV) wamagciwane, afana ne-SARS-CoV kanye ne-MERS-CoV, yachazwa ngonyaka ka-2017, futhi isaphenywa njengokwelashwa okungaba khona kwezifo ze-SARS-CoV-2.